What Is Disintegrant PVPP (Crospovidone) and How Is It Used in Tablets?

27, Oct. 2026

 

What Is Disintegrant PVPP (Crospovidone) and How Is It Used in Tablets?

Disintegrant PVPP is crosslinked polyvinylpyrrolidone, commonly called crospovidone. It is an insoluble pharmaceutical excipient used to help tablets break apart after contact with liquid, so their ingredients can disperse for subsequent dissolution. Formulators commonly evaluate crospovidone at about 2–5% by tablet weight, but the right level depends on the formula, manufacturing process, and target product performance.

If you are looking for more details, kindly visit our website.

Crospovidone works mainly by drawing liquid into a tablet’s structure and promoting particle separation. It can be incorporated into a formulation during granulation, added to the finished granule blend, or divided between these stages. For B2B buyers, choosing a suitable grade means looking beyond the name: particle characteristics, compendial requirements, documentation, packaging, and supply consistency all matter.

Key Takeaways

  • PVPP used as a tablet disintegrant is typically referred to as crospovidone or crosslinked PVP.
  • Its principal role is to help a tablet break apart when exposed to liquid; it does not replace the need to evaluate dissolution and other finished-product attributes.
  • A commonly used formulation starting range is approximately 2–5% w/w. This is a guide for development, not a guaranteed optimum or a substitute for product-specific testing.
  • Buyers should confirm the required grade, specifications, documentation, packaging, and supply expectations with the supplier before ordering.

What Is Disintegrant PVPP?

PVPP stands for polyvinylpolypyrrolidone, a crosslinked form of polyvinylpyrrolidone (PVP). Unlike soluble PVP grades used for other functions, crospovidone is generally used as an insoluble, water-insoluble disintegrant in solid dosage forms. “Crospovidone” is the common pharmaceutical name buyers will often see in product and formulation discussions.

In a tablet, a disintegrant helps the compact break into smaller fragments after liquid reaches it. This breakup is an important step in the product’s performance, but it is not the same as complete dissolution of the active ingredient. The formulation, tablet structure, processing conditions, and properties of the active ingredient can all affect the final result.

How Crospovidone Functions in Tablets

Liquid uptake and tablet breakup

Crospovidone helps liquid penetrate the tablet and encourages the compact to break apart. Its disintegrant action is commonly associated with liquid uptake and recovery of deformation within the compressed tablet. These effects can help disrupt the bonds between particles, although their contribution depends on how the excipient is used and on the rest of the formulation.

Because crospovidone is crosslinked and insoluble, it is not intended to dissolve and disappear like a soluble binder. Instead, it supports physical breakup of the dosage form. Formulators should assess this function alongside hardness, friability, disintegration, and dissolution rather than treating any single test as a complete measure of product quality.

Where it is added during manufacturing

In a direct-compression process, crospovidone may be blended with the other dry ingredients before the blend is compressed. In a wet-granulation process, a formulator may add part of the disintegrant during granulation and reserve part for addition to the dried granules. This split addition is often called intra- and extragranular use.

The best addition strategy is formulation-specific. Adding the material at different stages can change how it is distributed through the tablet and how it contributes to breakup. A development team should compare practical alternatives using its own process and finished-product criteria rather than assume that one method is universally superior.

Applications and Material Options

Crospovidone is used primarily as a disintegrant in tablets, including products made by direct compression or granulation. It may also be considered in other solid dosage forms where rapid breakup is a formulation objective. Its suitability depends on the product’s composition, manufacturing method, and applicable regulatory requirements.

Suppliers may offer different crospovidone grades or product options. These can vary in attributes such as particle-size distribution, bulk behavior, or handling characteristics; the exact options and naming conventions are supplier-specific. Buyers should obtain the current product specification for the grade under consideration instead of relying on a generic grade label.

NKY Group supply professional and honest service.

Key Specifications to Review

Before purchasing, compare the supplier’s specification with the requirements for your intended application and market. Relevant items may include identity, assay or other chemical tests, water content, particle-size information, and physical properties. Which tests and limits apply depends on the product grade and the relevant compendial or customer requirements.

Also confirm what documentation is available for the specific lot and intended use. Depending on your quality system and destination market, you may need documents such as a certificate of analysis, safety data sheet, or other technical and regulatory information. Do not assume a document, certification, or compendial status is available unless the supplier has confirmed it for the product being quoted.

Evaluation area What buyers should confirm
Product identity That the material is the intended crosslinked PVP/crospovidone grade.
Quality requirements Applicable specification limits, test methods, and lot documentation.
Physical properties Available particle and handling information relevant to blending and processing.
Supply details Packaging options, minimum order quantity, lead time, and shipment requirements.

How to Select PVPP for a Tablet Project

Start with the formulation and process

Define whether the product will be made by direct compression or granulation, and identify the performance issue the disintegrant is expected to address. Consider the active ingredient’s properties, other excipients, tablet dimensions, compression conditions, and the desired balance between mechanical strength and breakup. These factors help determine whether a particular grade or addition strategy is worth evaluating.

For early formulation screening, a development team might compare crospovidone levels of 2%, 4%, and 5% w/w, adjusting the rest of the formula accordingly. For a 100 g blend, those levels correspond to 2 g, 4 g, and 5 g of crospovidone, respectively. These are illustrative screening points within a commonly used range, not product-specific recommendations; the team should set its own test plan and confirm performance with suitable methods.

Assess the evidence from trials

Review disintegration and dissolution results together with relevant mechanical and manufacturing measures. Observe whether the material blends consistently and whether tablet properties remain suitable across the conditions being evaluated. If performance is inconsistent, investigate the complete formulation and process before concluding that the excipient grade alone is responsible.

Ask the supplier for product-specific technical information that helps you interpret and reproduce the trial. Useful discussions can cover grade availability, specification details, recommended storage and handling instructions, packaging, and lot-to-lot documentation. Keep the final selection tied to your own quality requirements and validated manufacturing process.

Buyer Considerations and Supplier Support

For procurement, technical suitability is only one part of the decision. Confirm the required volume, destination, delivery schedule, packaging format, and any documentation needed for qualification. Minimum order quantities and lead times can vary by grade, order size, and shipping destination, so request current terms rather than treating them as fixed across suppliers.

NKY Group can discuss crospovidone requirements with buyers seeking a supply partner for tablet excipients. Share the intended application, target grade or specification, expected volume, destination market, and required documentation when requesting information. This helps our team clarify product availability and provide a relevant quotation without assuming that every grade or service option fits every project.

Conclusion

Disintegrant PVPP, or crospovidone, is crosslinked PVP used to help tablets break apart after liquid enters the compact. It is commonly considered at approximately 2–5% w/w, with the appropriate level and addition method determined through product-specific formulation work. It supports tablet breakup, but finished-product performance must be assessed using the methods and requirements relevant to the product.

For your next step, define the process, target specification, required documents, and purchase volume, then request current grade information and a quotation from NKY Group. Compare candidate materials in your formulation trials and select the option that meets both your technical and sourcing requirements.

Are you interested in learning more about Disintegrant pvpp? Contact us today to secure an expert consultation!